GETINGE (OTCMKTS:GNGBY) Reaches New 52-Week High - Should You Buy?

Key Points

• Getinge's stock reached a new 52-week high at $22.88, finishing the trading day at $22.80 with a volume of 2,145 shares.
• Analysts from Sanford C. Bernstein have upgraded Getinge's rating to a "hold", with a consensus rating of "Hold" from one research analyst.
• In its last quarterly earnings report, Getinge reported earnings per share (EPS) of $0.23 and revenue of $852.59 million, with a net margin of 4.24%.

GETINGE (OTCMKTS:GNGBY - Get Free Report)'s stock price reached a new 52-week high during trading on Monday . The stock traded as high as $22.88 and last traded at $22.80, with a volume of 2145 shares traded. The stock had previously closed at $22.66.

Analyst Upgrades and Downgrades

Separately, Sanford C. Bernstein raised shares of GETINGE to a "hold" rating in a research report on Tuesday, June 17th. One investment analyst has rated the stock with a Hold rating, According to data from MarketBeat, GETINGE presently has an average rating of "Hold".

GETINGE Price Performance

The business's 50-day moving average is $21.14 and its 200-day moving average is $20.36. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.70 and a current ratio of 1.22.

GETINGE (OTCMKTS:GNGBY - Get Free Report) last issued its earnings results on Friday, July 18th. The company reported $0.23 earnings per share (EPS) for the quarter. The business had revenue of $852.59 million during the quarter. GETINGE had a net margin of 4.24% and a return on equity of 10.46%.

About GETINGE

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, mechanical circulatory support, advanced patient monitoring, ICU infrastructure equipment, patient flow management, and drainage solutions.